European Pharmaceutical Review

MARCH 27, 2024

percent from 2023 to 2032, according to the research. Drivers of the pyrogen testing market Increased R&D activities within the pharmaceutical and biopharmaceutical sector and a focus on biologics, were reported to hold significant growth opportunities for the pyrogen testing market. billion by 2032.

Safety 68

Safety Marketing Food and Drug Administration Pharmaceutical 68

European Pharmaceutical Review

JANUARY 26, 2023

These concentration measurements are used as part of regulatory decisions regarding the safety and efficacy of medicinal products. Implementation of the ICH M10 document The EU date of coming into effect of the core ICH M10 document and the corresponding Q&As was 21 January 2023.

Food and Drug Administration 87

Food and Drug Administration Medicine Pharmaceutical products Pharmaceutical 87

Pharmaceutical Technology

MARCH 22, 2023

Various uses soon became apparent including those for supply chain management, anti-counterfeiting, and to improve patient safety. The US Food and Drug Administration (FDA) has provided guidance for the use of RFID in the drug supply chain and to standardise the data format.

Food and Drug Administration 105

Food and Drug Administration Electronics Pharma FDA 105

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. market (source: IQVIA MIDAS, May 2023). billion people in 2023). in the top five European Union markets and 7.1%

Marketing 105

Marketing Insurance Medical Manufacturing 105

European Pharmaceutical Review

DECEMBER 27, 2023

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. 10 Benefits of point-of-care CAR T-cell therapy Even after validation of the efficacy and safety of the therapy, two critical challenges remained – affordability and accessibility.

Manufacturing 82

Manufacturing Food and Drug Administration Patients Pharma 82